Abstract
Metabolic alkalosis is a metabolic condition with an elevated pH beyond the normal range (7.35–7.45). This is the result of primarily increased bicarbonate plasma concentrations or decreased hydrogen ion concentration leading to a relative excess of plasma bicarbonate. Secondary or compensatory processes that cause an elevation in plasma bicarbonate should be separated from primary processes [1, 2].
Conflict of Interest
The authors declare that there is no conflict of interest in relation to this article.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
1 Definition
Metabolic alkalosis is a metabolic condition with an elevated pH beyond the normal range (7.35–7.45). This is the result of primarily increased bicarbonate plasma concentrations or decreased hydrogen ion concentration leading to a relative excess of plasma bicarbonate. Secondary or compensatory processes that cause an elevation in plasma bicarbonate should be separated from primary processes [1, 2].
2 Pathophysiology
Three main mechanisms lead to the development of a metabolic alkalosis:
-
1.
Net loss of hydrogen ions from the extracellular fluid (ECF), either gastrointestinal or renal
-
2.
Net addition of bicarbonate or bicarbonate precursors to the ECF
-
3.
External loss of fluids containing high chloride but low bicarbonate concentrations (leading to the so-called contraction alkalosis)
The initiating processes for metabolic alkalosis may be a gain of alkali in the ECF (extracellular fluid) from an exogenous or an endogenous source or the loss of protons from ECF via kidneys or via the stomach. Beside hepatic metabolism of citrate, lactate or acetate to bicarbonate can cause a brief metabolic alkalosis. Chloride depletion reduced glomerular filtration rate (GFR), potassium depletion and ECF volume depletion can lead to persisting metabolic alkalosis [3, 4].
In some disorders (e.g. vomiting), volume depletion and potassium depletion may coexist. Severe potassium depletion alone can cause a metabolic alkalosis but typically of a mild to moderate degree. The mechanism is related to an intracellular shift of H+ in exchange for K+. While alkalosis is generated predominantly due to non-renal mechanisms, renal mechanisms are frequently involved in potassium depletion [5].
Volume depletion is implicated in maintenance of alkalosis since hypovolaemia is associated with increased fluid and sodium reabsorption in the proximal renal tubule. Bicarbonate is reabsorbed in preference to chloride, leading to maintenance of alkalosis [6]. Nevertheless, the coexisting chloride depletion is the most important factor for the persistence of alkalosis.
Diuretics can cause excess renal loss of nonvolatile (= fixed) acid anions and result in alkalosis. Their use can lead to depletion of chloride, water, and potassium. These factors together maintain the alkalosis.
Renal compensation for metabolic alkalosis consists of increased excretion of bicarbonate, as the filtered load of bicarbonate exceeds the ability of the renal tubule to reabsorb it, which is only efficiently excreted if concentration exceeds 24 mmol/l. Impairment of renal bicarbonate excretion can in turn cause persistence of the metabolic alkalosis. Since renal compensation for metabolic alkalosis is much more effective than respiratory, metabolic alkalosis rarely occurs in healthy renal status. However, in pathological renal status, compensatory mechanisms for metabolic alkalosis are mainly respiratory. Hypoventilation leads to the retention of carbon dioxide (CO2), which is then transformed to carbonic acid, thus decreasing pH. In turn, PCO2 is increased inhibiting hypoventilation by stimulating central chemoreceptors sensitive to the partial pressure of CO2 increasing respiration again [7–9].
In urological care metabolic alkalosis may also be caused by excess intake of bicarbonate applied for correction of metabolic acidosis related to continent urinary diversion.
3 Diagnostic and Differential Diagnosis
While dehydration is the most prominent clinical symptom of metabolic alkalosis, symptoms often may not be noticeable [10]. Laboratory tests show blood pH >7.45. Levels of potassium, sodium, and chloride fall below normal ranges. Bicarbonate levels in the blood will usually exceed 29 mEq/l. Urine pH may rise to 7.0.
Assessment of urinary chloride can be useful and define two subgroups: Firstly, urinary chloride levels lower than 10 mmol/l usually originate from previous thiazide diuretic therapy, from vomiting, or in fewer cases from volume depletion with increased proximal tubular reabsorption of bicarbonate or from saline infusion. Secondly, urinary chloride levels higher than 20 mmol/l originate from severe hypokalaemia, current diuretic therapy, or Bartter’s syndrome and are often associated with volume expansion and resistance to therapy with saline infusion. The urinary chloride/creatinine ratio may be elevated in extra-renal alkalosis [6]. Table 16.1 shows differential diagnoses for metabolic alkalosis.
4 Treatment
While the underlying cause of metabolic alkalosis must be corrected, symptomatic treatment focuses on correcting the aforementioned imbalances. Intravenous correction of hypovolaemia, chloride, or potassium is indicated in more severe cases. Drugs to regulate blood pressure or heart rate or to control nausea and vomiting might be given. Vital signs like pulse, respiration, blood pressure, and body temperature will be monitored [10]. Figure 16.1 demonstrates the typical pathway of metabolic alkalosis.
References
Khanna A, Kurtzman NA. Metabolic alkalosis. Respir Care. 2001;46:354–65.
Pahari DK, Kazmi W, Raman G, et al. Diagnosis and management of metabolic alkalosis. J Indian Med Assoc. 2006;104:630–4, 636.
Driscoll DF, Bistrian BR, et al. Development of metabolic alkalosis after massive transfusion during orthotopic liver transplantation. Crit Care Med. 1987;15:905–8.
Berger BE, Cogan MG, Sebastian A. Reduced glomerular filtration and enhanced bicarbonate reabsorption maintain metabolic alkalosis in humans. Kidney Int. 1984;26:205–8.
Hernandez RE, Schambelan M, Cogan MG, et al. Dietary NaCl determines severity of potassium depletion-induced metabolic alkalosis. Kidney Int. 1987;31:1356–67.
Palmer BF, Alpern RJ. Metabolic alkalosis. J Am Soc Nephrol. 1997;8:1462–9.
Gluck SL. Acid-base. Lancet. 1998;352:474–9.
Gennari FJ. Pathophysiology of metabolic alkalosis: a new classification based on the centrality of stimulated collecting duct ion transport. Am J Kidney Dis. 2011;58:626–36.
Jacobson HR. Medullary collecting duct acidification. Effects of potassium, HCO3 concentration, and pCO2. J Clin Invest. 1984;74:2107–14.
Webster NR, Kulkarni V. Metabolic alkalosis in the critically ill. Crit Rev Clin Lab Sci. 1999;36:497–510.
Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. Second of two parts. N Engl J Med. 1998;338:107–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gierth, M., Banas, B., Burger, M. (2014). Metabolic Alkalosis. In: Merseburger, A., Kuczyk, M., Moul, J. (eds) Urology at a Glance. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54859-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-54859-8_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54858-1
Online ISBN: 978-3-642-54859-8
eBook Packages: MedicineMedicine (R0)